New treatment for urinary tract cancer could prevent kidney dialysis, transplant

by Michelle Brubaker,University of California - San DiegoCredit: Pixabay/CC0 Public DomainUC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial c

Updated on: January 02,2024

New treatment for urinary tract cancer could prevent kidney dialysis, transplant

by Michelle Brubaker,University of California - San DiegoCredit: Pixabay/CC0 Public DomainUC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial c

Updated on:January 02,2024

Progress slow against pancreatic cancer

by Scott Gilbert,Pennsylvania State UniversityAcute exudative pancreatitis on CT scan. Credit: Hellerhoff/WikipediaPancreatic cancer is the third deadliest form of the disease after lung cancer

Updated on: May 13,2024

Progress slow against pancreatic cancer

by Scott Gilbert,Pennsylvania State UniversityAcute exudative pancreatitis on CT scan. Credit: Hellerhoff/WikipediaPancreatic cancer is the third deadliest form of the disease after lung cancer

Updated on:May 13,2024

Safer, swifter, smaller scar: New brain surgery approach targets difficult tumors at skull base

Updated on: July 05,2024

Safer, swifter, smaller scar: New brain surgery approach targets difficult tumors at skull base

Updated on:July 05,2024

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on: October 21,2024

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on:October 21,2024

An elusive mechanism of wasting syndrome cachexia revealed

by Justin Jackson , Medical XpressOSM induces Eda2r expression in muscle and the depletion of OSMR protects from muscle wasting. a, Mouse primary myotubes were treated with recombinant TNFα, IL-6, LIF

Updated on: February 01,2024

An elusive mechanism of wasting syndrome cachexia revealed

by Justin Jackson , Medical XpressOSM induces Eda2r expression in muscle and the depletion of OSMR protects from muscle wasting. a, Mouse primary myotubes were treated with recombinant TNFα, IL-6, LIF

Updated on:February 01,2024

Researchers reveal why obesity makes ovarian cancer more deadly

by Brett Beasley,University of Notre DameElizabeth Harper, who received her doctorate in the Integrated Biomedical Sciences Graduate Program at the University of Notre Dame, served as a co-autho

Updated on: January 30,2024

Researchers reveal why obesity makes ovarian cancer more deadly

by Brett Beasley,University of Notre DameElizabeth Harper, who received her doctorate in the Integrated Biomedical Sciences Graduate Program at the University of Notre Dame, served as a co-autho

Updated on:January 30,2024

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on: March 09,2024

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on:March 09,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024

Blood-borne cancer detection receives gold-plated boost

by Lachlan Gilbert,University of New South WalesA computer representation of the gold coated nanoparticles that make up the dispersible electrodes. These are modified with DNA that gives an elec

Updated on: March 06,2024

Blood-borne cancer detection receives gold-plated boost

by Lachlan Gilbert,University of New South WalesA computer representation of the gold coated nanoparticles that make up the dispersible electrodes. These are modified with DNA that gives an elec

Updated on:March 06,2024

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Updated on: May 27,2024

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Updated on:May 27,2024

Breast cancer study confirms importance of multigenerational family data to assess risk

by Columbia University's Mailman School of Public HealthMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA team of researchers led by Columbia

Updated on: March 01,2024

Breast cancer study confirms importance of multigenerational family data to assess risk

by Columbia University's Mailman School of Public HealthMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA team of researchers led by Columbia

Updated on:March 01,2024

Fighting aggressive blood cancer ages and exhausts immune cells, study shows

byNottingham Trent UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI159579Scientists at Nottingham Trent University and John Hopkins Kimm

Updated on: January 22,2024

Fighting aggressive blood cancer ages and exhausts immune cells, study shows

byNottingham Trent UniversityGraphical abstract. Credit:Journal of Clinical Investigation(2022). DOI: 10.1172/JCI159579Scientists at Nottingham Trent University and John Hopkins Kimm

Updated on:January 22,2024